Pursuant to composite scheme of arrangementJubilant Pharmova announced that pursuant to the Composite Scheme of Arrangement amongst HSB Corporate Consultants, Jubilant Stock Holding, SSB Consultants & Management Services, JCPL Life Science Ventures and Holdings and JSPL Life Science Services and Holdings (collectively, the Transferor Companies ), Jubilant Pharmova (the Transferee Company or the Demerged Company ) and Jubilant Ingrevia (the Resulting Company ) and their respective shareholders and creditors (the Composite Scheme ), Non-Convertible Debentures
of Rs. 100 crore issued by the Company on Private Placement basis has been transferred by the Company in the books of account of Jubilant Ingrevia.
Record Date for suspension of trading of the NCDs of Rs. 100 crore under the name of Jubilant Pharmova is Thursday, 20 May 2021. Post suspension of the NCDs, these NCDs shall be listed by Jubilant Ingrevia.
Jubilant Life Sciences announced that the Hon ble National Company Law Tribunal, Allahabad Bench ( NCLT ) has, by its Order dated 23 December 2020, sanctioned the Composite Scheme of Arrangement under Sections 230 to 232 read with Section 66 and other applicable provisions of the Companies Act, 2013 amongst HSB Corporate Consultants, Jubilant Stock Holding, SSB Consultants & Management Services, JCPL Life Science Ventures and Holdings, JSPL Life Science Services and Holdings, Jubilant Life Sciences and Jubilant Ingrevia and their respective shareholders and creditors.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) Dear Reader,